Hengrui’s Vunakizumab Receives NMPA Approval for nr-axSpA Treatment
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received another clinical trial...
GE Healthcare Posts 1% Annual Revenue Growth in 2024 Financials
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) released its...
Betta Pharma Files for EMA Approval of ALK Inhibitor Ensartinib
Betta Pharmaceuticals (SHE: 300558) announced the initiation of a market approval filing with the European...
Lee Kai and Yangshun Partner on Polyvinyl Alcohol Embolization Microspheres
Chinese companies Shanghai Lee Kai Technology Co., Ltd (Kai Medtech) and Hangzhou Yangshun Medical Technology...
Nanos Medical Raises Over RMB300m to Boost Otolaryngology Device Lead
China-based Nanos Medical (Shanghai) Limited, an otolaryngology device maker, has reportedly raised over RMB300 million...
SciClone’s Vibativ Approved by NMPA for HABP/VABP Treatment
China-based SciClone Pharmaceuticals Inc. announced that it has received market approval from the National Medical...
Trinomab’s Antitetanus mAb Injection TNM002 Approved by NMPA
China-based Trinomab Biotech Co., Ltd has received market approval for its antitetanus toxin monoclonal antibody...
NMPA Releases 90th Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 90th batch of reference drugs for...
Accropeutics Doses First Patient in AC-101 Phase Ib UC Study
Accro Bioscience (Suzhou) limited, better known as Accropeutics, a clinical-stage biotech operating out of New...
China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility
In a bid to bolster public health infrastructure and improve healthcare services, China’s National Health...
Sanofi and J&J’s E. coli Vaccine Fails Phase III Study
France-based Sanofi (NASDAQ: SNY) and US giant Johnson & Johnson’s (J&J, NYSE: JNJ) vaccine candidate...
Antengene’s Xpovio Included in Taiwan’s NHI Drug List for Myeloma Treatment
China-based biopharma Antengene Corp., Ltd (HKG: 6996) announced that its Xpovio (selinexor), the world’s first...
Boehringer Ingelheim Partners with ExpressionEdits on Gene Therapy Tech
German pharmaceutical giant Boehringer Ingelheim has entered into a collaboration and licensing agreement with UK-based...
Merck’s Zerbaxa Approved by China’s NMPA for Complex Infections
US-based pharmaceutical giant Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) announced that it has...
Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation
In-Depth Analysis and Orientation Guide for Hainan’s Biomedical New Technology PolicyThe Hainan Provincial Health Commission,...
Roche’s Evrysdi Tablet Approved by FDA for Spinal Muscular Atrophy
Swiss giant Roche (SWX: ROG) has announced that it has received marketing approval from the...
Shanghai’s Ambitious Plan to Revolutionize Brain-Computer Interfaces
In-Depth Analysis and Orientation Guide for Shanghai’s Brain-Computer Interface (BCI) PolicyShanghai has unveiled a groundbreaking...
Pfizer’s Adcetris Gets New FDA Approval for Lymphoma Treatment
US giant Pfizer (NYSE: PFE) has announced that it has received another indication approval from...
StairMed Raises Record RMB350m for Implantable BCI Development
Shanghai StairMed Technology Co., Ltd., a specialist in implantable brain-computer interface (BCI) technology, has reportedly...
Lundbeck’s Amlenetug Receives FDA Fast Track for Multiple System Atrophy
Denmark-based pharma company Lundbeck A/S (VIE: LUNB) has announced that it has received Fast Track...